Effects of slow breathing exercises on heart health and quality of life after heart procedures
The Effect of Slow Breathing Exercise Applied to Patients After Primary Percutaneous Coronary Intervention on Pulse, Blood Pressure and Quality of Life
This study is testing if slow breathing exercises can help improve heart health and quality of life for patients who have had heart procedures after a heart attack.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06098222 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of slow breathing exercises on heart rate, blood pressure, and quality of life in patients who have undergone Primary Percutaneous Coronary Intervention (PCI) following ST Elevation Myocardial Infarction (STEMI). A total of 80 patients will be randomly assigned to either an experimental group, which will receive training in slow breathing exercises, or a control group. The experimental group will practice these exercises at home for 10 minutes twice daily over eight weeks. Data will be collected to assess the effectiveness of this intervention on their cardiovascular health and overall well-being.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-65 who have undergone PCI for STEMI and meet specific health criteria.
Not a fit: Patients with significant mental or psychiatric disorders or those who have received fibrinolytic therapy prior to PCI may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and improve quality of life for patients after heart procedures.
How similar studies have performed: Previous studies have shown positive outcomes with slow breathing techniques in various patient populations, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young adult patients between the ages of 18-65, * Patients who have not received fibrinolytic therapy before or simultaneously with Percutaneous Coronary Intervention (PCI) procedure, * Patients who have passed 24 hours after the PCI procedure, * Patients with a pulse \> 60/min (whether or not beta blockers are used after PCI), * Patients without rhythm problems, * Patients with hypertension (systolic blood pressure 140-179 mmHg, diastolic blood pressure 90-109 mmHg), (whether or not they use antihypertensive and beta blocker drugs), * Patients without a diagnosis of mental or psychiatric disease, * Patients who have the materials to watch the breathing exercise video, * Patients who can receive reminder messages and make video calls (with devices such as a smartphone, computer, tablet, etc.), * Patients with a portable blood pressure monitor suitable for pulse and blood pressure measurement during home monitoring (the necessary equipment will be provided within the scope of the TUBITAK project), * Patients without hearing or visual impairment, * Patients who can read and write * Patients who can communicate, * Patients without language problems, * Patients who volunteer and indicate this verbally and in writing Exclusion Criteria: * Patients with elective/appointed appointments for whom PCI is planned in advance, * Patients whose PCI procedure failed, * Patients who underwent only thrombus aspiration and balloon angioplasty during the PCI procedure, * Patients who have previously undergone PCI and at least one year has not passed since, * Patients who do not comply with planned interventions, * Patients who do not volunteer to participate in the study, * Patients with physical limitations and respiratory distress who cannot do breathing exercises, * Patients with rhythm problems, * Patients with diseases that can increase heart rate (anemia, hyperthyroidism, hyperthermia, infection), * Patients who are morbidly obese (Body Mass Index \> 40 kg/m2), * Patients with hearing impairment, * Patients with mental disabilities or perception problems, * Patients who have previously received breathing therapy training will not be included in the study.
Where this trial is running
Istanbul
- Istanbul Provincial Directorate of Health Koşuyolu High Specialization Education and Research Hospital — Istanbul, Turkey (Recruiting)
Study contacts
- Principal investigator: Melike CELIK, Lecturer — Marmara University
- Study coordinator: Melike CELIK, Lecturer
- Email: melike.celik@marmara.edu.tr
- Phone: 905321562205
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.